Professor and Vice Chair, Department of Computational and Systems Biology, University of Pittsburgh School of Medicine
Takis Benos received his undergraduate degree in Mathematics but later he was attracted to Molecular Biology. He earned a PhD degree for his work on the molecular cloning and phylogenetic characterization of alcohol dehydrogenase genes in Diptera. His post-graduate work included genome analysis and annotation of Drosophila melanogaster with Michael Ashburner (EMBL-EBI, Cambridge, U.K.) and the development of probabilistic algorithms for modelling protein-DNA interactions with Gary Stormo (Washington University in St. Louis, St. Louis, MO). In 2002 he joined University of Pittsburgh and he is currently a tenured Full Professor and Vice Chair for Academic Affairs at the Department of Computational and Systems Biology (primary appointment), the Department of Biomedical Informatics (secondary appointment), School of Medicine and the Department of Computer Science (secondary appointment), Faculty of Arts and Sciences, University of Pittsburgh. He also holds a joint appointment at the University of Pittsburgh Cancer Institute (UPCI).
Dr. Benos’ research interests are in the area of computational biology and in particular in the integration of –omics data with clinical variables and the study of gene regulatory networks and their association to disease. In the past, his group has developed models of transcription factor interactions to DNA and miRNA interactions to mRNAs and algorithms to identify subnetwork motifs associated to chronic diseases. His work has been published in peer-reviewed journals such as Nature, Science, PNAS, PLoS Computational Biology, Genome Research, Genome Biology, etc. His work has been presented in many international conferences and he has been invited to give talks in many Universities in United States and Europe. In April 2014, he co-organized and co-chaired the RECOMB 2014 conference in Pittsburgh, which is one of the three largest computational biology conferences. Dr. Benos has been continuously funded through his own NIH and NSF grants since 2003 and he has established a large number of collaborations.